| Institution: | 1. Princess Margaret Cancer Centre, Ontario Cancer Institute, Toronto, ON, Canada;;2. Division of Stem Cell and Developmental Biology, Campbell Family Institute for Cancer Research/Ontario Cancer Institute, Toronto, ON, Canada; and;3. Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON, Canada;1. Department of Architecture Construction Conservation, University IUAV of Venezia, Dorsoduro 2206, 30123 Venezia, Italy;2. Department of Engineering, University of Ferrara, Via G. Saragat 1, 44122 Ferrara, Italy;1. Tianjin Neurological Institute, Department of Neurosurgery, General Hospital, Tianjin Medical University, Tianjin, China;;2. Puget Sound Blood Research Institute, Seattle, WA;;3. Institute of Pathology, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China;;4. Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, WA;;5. Departments of Pathology and Medicine, Baylor College of Medicine, Houston, TX; and;6. Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, TX;1. Laboratory for Genomics in Myeloma, Institut Universitaire du Cancer and University Hospital, Toulouse, France;;2. Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Toulouse, France;;3. Unité Mixte de Génomique du Cancer, University Hospital, Nantes, France;;4. INSERM U892, Nantes, France;;5. Service d’Epidémiologie, University Hospital, Toulouse, France;;6. Hematology Department, University Hospital, Dijon, France;;7. Hematology Department, University Hospital, Nancy, France;;8. Hematology Department, University Hospital, Lille, France;;9. Hematology Department, University Hospital, Bordeaux, France;;10. Hematology Department, University Hospital, Lyon, France;;11. Hematology Department, University Hospital, Toulouse, France;;12. Hematology Department, Institut Paoli-Calmettes, Marseille, France;;13. Hematology Department, Henri Mondor University Hospital, Créteil, France;;14. Hematology Department, General Hospital, Chalon sur Saone, France;;15. Hematology Department, Saint-Antoine University Hospital, Paris, France;;16. Hematology Department, University Hospital, Caen, France;;17. Hematology Department, University Hospital, Nantes, France; and;18. LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana–Farber Cancer Institute, Harvard Medical School, Boston, MA;1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX;;2. Department of Internal Medicine, University of Texas Medical School at Houston, Houston, TX; and;3. Pharmacyclics, Inc, Sunnyvale, CA |
